Skip to main content
. Author manuscript; available in PMC: 2014 Apr 24.
Published in final edited form as: Brain Res. 2013 Feb 21;1507:97–104. doi: 10.1016/j.brainres.2013.02.023

Fig. 5.

Fig. 5

Effects of 3K3A-APC late multiple dose therapy on functional recovery and infarct volume in F2r−/− mice within 7 days of dMCAO. Forelimb use asymmetry test (A), foot-fault test (B), infarct volume (C) and edema volume (D) in F2r−/− mice on C57Bl6 background treated with 3K3A-APC (0.8 mg/kg intraperitoneally at 12 h, 1, 3, 5 and 7 days after onset of ischemia) or vehicle. Mean±SEM, n = 5 mice/group.